Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Neurocognitive functioning and cannabis use in schizophrenia.

Segev A, Lev-Ran S.

Curr Pharm Des. 2012;18(32):4999-5007. Review.

PMID:
22716156
2.

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.

Rabin RA, Zakzanis KK, George TP.

Schizophr Res. 2011 May;128(1-3):111-6. doi: 10.1016/j.schres.2011.02.017. Epub 2011 Mar 21. Review.

PMID:
21420282
3.

Neurocognitive functions of heavy cannabis using schizophrenia patients.

Lev-Ran S, Segev A, Braw Y, Levkovitz Y.

Eur Psychiatry. 2012 Jul;27(5):365-8. doi: 10.1016/j.eurpsy.2011.04.010. Epub 2011 Jun 24.

PMID:
21704501
4.

Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.

Scholes KE, Martin-Iverson MT.

Psychol Med. 2010 Oct;40(10):1635-46. doi: 10.1017/S0033291709992078. Epub 2009 Dec 17.

PMID:
20018124
5.

Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.

Ringen PA, Vaskinn A, Sundet K, Engh JA, Jónsdóttir H, Simonsen C, Friis S, Opjordsmoen S, Melle I, Andreassen OA.

Psychol Med. 2010 Aug;40(8):1337-47. doi: 10.1017/S0033291709991620. Epub 2009 Nov 6.

PMID:
19891810
6.

Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.

Rentzsch J, Buntebart E, Stadelmeier A, Gallinat J, Jockers-Scherübl MC.

Schizophr Res. 2011 Aug;130(1-3):222-7. doi: 10.1016/j.schres.2011.05.011. Epub 2011 May 31.

PMID:
21624823
7.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
8.

Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.

Mata I, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, González-Blanch C, Ramírez-Bonilla M, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B.

Psychol Med. 2008 Sep;38(9):1257-66. Epub 2007 Nov 16.

PMID:
18005495
9.

The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.

Coulston CM, Perdices M, Tennant CC.

Schizophr Res. 2007 Nov;96(1-3):169-84. Epub 2007 Sep 10.

PMID:
17826035
10.

[Acute and chronic cognitive disorders caused by cannabis use].

Karila L, Vignau J, Alter C, Reynaud M.

Rev Prat. 2005 Jan 15;55(1):23-6; discussion 27-9. French.

PMID:
15801393
11.

Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.

Ringen PA, Melle I, Berg AO, Agartz I, Spigset O, Simonsen C, Sundet K, Andreassen OA.

Schizophr Res. 2013 Jan;143(1):84-9. doi: 10.1016/j.schres.2012.10.021. Epub 2012 Nov 22.

PMID:
23178107
12.

Cannabis, cannabinoids and schizophrenia: integration of the evidence.

Cohen M, Solowij N, Carr V.

Aust N Z J Psychiatry. 2008 May;42(5):357-68. doi: 10.1080/00048670801961156. Review.

PMID:
18473254
13.

Effects of cannabis use status on cognitive function, in males with schizophrenia.

Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP.

Psychiatry Res. 2013 Apr 30;206(2-3):158-65. doi: 10.1016/j.psychres.2012.11.019. Epub 2012 Dec 13.

PMID:
23246245
14.

Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.

Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J.

Biol Psychiatry. 2004 Oct 15;56(8):560-9.

PMID:
15476685
15.

Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Sánchez-Torres AM, Basterra V, Rosa A, Fañanás L, Zarzuela A, Ibáñez B, Peralta V, Cuesta MJ.

Eur Arch Psychiatry Clin Neurosci. 2013 Dec;263(8):643-53. doi: 10.1007/s00406-013-0404-5. Epub 2013 Apr 12.

PMID:
23580110
16.

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.

Meijer JH, Dekker N, Koeter MW, Quee PJ, van Beveren NJ, Meijer CJ; Genetic Risk and Outcome of Psychosis (GROUP) Investigators.

Psychol Med. 2012 Apr;42(4):705-16. doi: 10.1017/S0033291711001656. Epub 2011 Sep 7.

PMID:
21899795
17.

Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.

Bourque J, Mendrek A, Durand M, Lakis N, Lipp O, Stip E, Lalonde P, Grignon S, Potvin S.

Psychiatry Res. 2013 Oct 30;214(1):24-32. doi: 10.1016/j.pscychresns.2013.05.012. Epub 2013 Jul 30.

PMID:
23906663
18.
19.
20.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365

Supplemental Content

Support Center